GlassScriptPhysician profile
Steve Goldwasser
NPI 1467427633
$3,551.21
in general payments reported to CMS, 2019-2025
23 companies · $276 in 2025
The $276 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $114 · 2021: $256 · 2022: $296 · 2023: $553 · 2024: $1,741 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,381 · Travel and Lodging: $1,134 · Education: $54.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,380.57 |
| Travel and Lodging | $1,134.21 |
| Education | $54.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,569.17 | 2020-2024 | Axonics |
| Astellas Pharma US INC | $458.96 | 2019-2025 | Myrbetriq, Veozah |
| Abbvie INC. | $300.11 | 2022-2025 | |
| Boston Scientific Corporation | $257.77 | 2021-2025 | Axonics, Upsylon, Advantage System |
| Coloplast Corp | $141.65 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $138.53 | 2023-2025 | Gemtesa |
| Caldera Medical, INC | $136.00 | 2022-2023 | Desara |
| Allergan, INC. | $128.52 | 2019-2022 | |
| Urovant Sciences INC | $76.44 | 2021-2022 | |
| Therapeuticsmd, INC. | $43.59 | 2019-2022 | |
| Bluewind Medical | $42.58 | 2024 | Revi |
| Intuitive Surgical, INC. | $40.00 | 2019 | |
| Medtronic, INC. | $35.81 | 2023 | Interstim |
| Theramicro, INC. | $31.72 | 2025 | Centavisc |
| Exact Sciences Corporation | $20.35 | 2023 | Cologuard Collection Kit |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Escala Medical INC. | $19.09 | 2024 | |
| Lsi Solutions INC | $18.14 | 2024 | Jnw Urtrac, Running Device, Fornisee |
| Daiichi Sankyo INC. | $17.90 | 2024 | Injectafer |
| Femselect INC. | $17.44 | 2025 | Enplace |
| Pacira Pharmaceuticals Incorporated | $16.78 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.84 | 2019 | |
| Medtronic USA, INC. | $13.49 | 2019 | |
| Avion Pharmaceuticals | $13.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Goldwasser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.